J

02126

JW (Cayman) Therapeutics

1.54

0.01+0.65%
Opening11:38 05/02 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE1.510/1.530
TODAY RANGE1.510-1.570
VOL33.50K
MARKET CAP640.80M
52 WEEK RANGE1.190-2.680
AVG VOL (3M)2.02M
% TURNOVER0.01%
TURNOVER51.27K
P/E (TTM)-1.005
% RANGE3.92%
EPS(TTM)-1.533
P/E(FORWARD)-0.982
P/B0.508
BVPS3.034
DIVIDEND--
P/S3.428
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP640.80M
SHARES OUTSTANDING416.11M
NEXT EARNINGS08/27-09/03
FREE FLOAT416.11M
LOT SIZE500
EX-DIV DATE--
Same Industry
Name/Symbol
Change%
Price

J

JW (Cayman) Therapeutics

02126

+0.65%
1.540

S

Shanghai Haohai Biological Technology

06826

-1.02%
24.300

W

Wuxi Apptec

02359

+6.23%
63.900

H

Hangzhou Tigermed Consulting

03347

-0.56%
26.600

J

JOINN Laboratories (China)

06127

-1.02%
9.730

P

Pharmaron Beijing

03759

+5.04%
14.180

B

BBI Life Sciences

01035

0.00%
3.490

F

Frontage Holdings

01521

-0.86%
1.150

C

China Regenerative Medicine International

08572

--
0.010

M

Mingyuan Medicare Development

00233

0.00%
0.230

C

China Health Group

08225

0.00%
0.151

M

Mabpharm

02181

0.00%
0.410

V

Viva Biotech Holdings

01873

+1.36%
1.490

C

China Regenerative Medicine International

08158

+1.45%
0.350

T

TOT Biopharm International

01875

-1.08%
1.840

H

Hua Medicine

02552

+0.45%
2.210

M

MicroPort NeuroScientific

02172

+1.14%
10.660

A

Alphamab Oncology

09966

+21.83%
7.870

S

SinoMab BioScience

03681

0.00%
1.580

L

Lepu Biopharma

02157

+1.79%
5.130

J

Jacobio Pharmaceuticals Group

01167

+2.86%
3.960
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.